|

IMids Clinical Trials

1 actively recruiting trial

Also known as: lenalidomide, pomalidomide

Pipeline

Phase 1: 1

Top Sponsors

  • Onward Therapeutics1

Indications

  • Hematological Malignancy1
  • Solid Tumor1
  • Cancer1

Other1 trial

First-in-human Study of OT-A201 in Patients With Selected Hematological Malignancies and Solid Tumors
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.